Impaired detection ofMycobacterium tuberculosisimmunity in patients using high levels of immunosuppressive drugs
Authors:
- U. SesterUSU. Sester
- H. WilkensHWH. Wilkens
- K. van BentumKBK. van Bentum
- M. SinghMSM. Singh
- G. W. SybrechtGSG. W. Sybrecht
- H-J. SchäfersHSH-J. Schäfers
- M. SesterMSM. Sester
Open Access
- 22 April 2009
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 34 (3) , 702-710
Abstract
We have previously shown, in renal transplant recipients on maintenance immunosuppression, that a whole-blood assay was superior in detecting immunity towards purified protein derivative (PPD) compared with skin testing. As blood tests may have limitations during high-dose immunosuppression therapy, the present study was aimed at characterising the effect of high immunosuppressive drug levels on PPD-specific T-cell immunity.PPD-reactive CD4 T-cells from 13 renal transplant recipients were longitudinally quantified by the induction of cytokines using flow cytometry. To further address the effect of high and low maintenance immunosuppression, drug effects were studiedin vitroand in 49 age-matched lung transplant recipients and 49 renal transplant recipients.Maintenance immunosuppression after renal transplantation did not affect PPD-specific T-cell detection (median T-cell frequencies 0.55% before and 0.46% >12 months after transplantation), whereas specific T-cell frequencies were significantly lower 3 months after transplantation (0.15%; p = 0.0002). Likewise, high-level maintenance immunosuppression after lung transplantation was associated with a significantly lower prevalence in PPD-specific T-cell reactivity compared with renal transplant recipients (16.7%versus52.1%; p = 0.0005). In line with the observations madein vivo, calcineurin inhibitors analysedin vitroled to a dose-dependent decrease in antigen-specific T-cell reactivity.The flow cytometric assay is not adversely affected by low drug doses. In contrast, decreased levels of PPD-specific T-cells early after transplantation and low prevalence of PPD-reactivity in lung transplant recipients suggest a reduced sensitivity ofin vitrotesting during high-level immunosuppression.Keywords
This publication has 28 references indexed in Scilit:
- Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF- blocking drugs using a novel flow-cytometric interferon- release assayRheumatology, 2007
- Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapyNephrology Dialysis Transplantation, 2006
- Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective studyThe Lancet, 2006
- Mycobacterium tuberculosis Infection in Recipients of Solid Organ TransplantsClinical Infectious Diseases, 2005
- Reactivation of Tuberculosis During Immunosuppressive Treatment in a Patient with a Positive QuantiFERON®-RD1 TestScandinavian Journal of Infectious Diseases, 2004
- The value of C2 monitoring in stable renal allograft recipients on maintenance immunosuppressionNephrology Dialysis Transplantation, 2004
- LEVELS OF VIRUS-SPECIFIC CD4 T CELLS CORRELATE WITH CYTOMEGALOVIRUS CONTROL AND PREDICT VIRUS-INDUCED DISEASE AFTER RENAL TRANSPLANTATION1Transplantation, 2001
- Specific immune-based diagnosis of tuberculosisThe Lancet, 2000
- Lifetime Risks, Incubation Period, and Serial Interval of TuberculosisAmerican Journal of Epidemiology, 2000
- Mycobacterium tuberculosisInfection in Solid‐Organ Transplant Recipients: Impact and Implications for ManagementClinical Infectious Diseases, 1998